Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-25-038798

Chief Legal Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sullivan Mark Chief Legal Officer 2025-03-12 Grant or award +150,000 323,197 D: show line 1 in the form
Loading xslF345X05/ownership.xml…